GeneDx Holdings Corp.GeneDx Holdings Corp.GeneDx Holdings Corp.

GeneDx Holdings Corp.

No trades
See on Supercharts
Market capitalization
‪257.41 M‬USD
−7.51USD
‪−175.77 M‬USD
‪202.57 M‬USD
‪16.22 M‬
Beta (1Y)
1.21

About GeneDx Holdings Corp.

CEO
Katherine A. Stueland
Website
Headquarters
Stamford
Employees (FY)
‪1 K‬
Founded
2015
ISIN
US81663L2007
FIGI
BBG00XDHY5P9
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of WGS is 9.61 USD — it has decreased by 2.73% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GeneDx Holdings Corp. stocks are traded under the ticker WGS.
GeneDx Holdings Corp. is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for GeneDx Holdings Corp. has a max estimate of 14.00 USD and a min estimate of 5.50 USD.
WGS earnings for the last quarter are −0.82 USD whereas the estimation was −1.31 USD which accounts for 37.36% surprise. Estimated earnings for the next quarter are −0.65 USD. See more details about GeneDx Holdings Corp. earnings.
GeneDx Holdings Corp. revenue for the last quarter amounts to ‪53.30 M‬ USD despite the estimated figure of ‪52.42 M‬ USD. In the next quarter revenue is expected to reach ‪54.24 M‬ USD.
Yes, you can track GeneDx Holdings Corp. financials in yearly and quarterly reports right on TradingView.
Like other stocks, WGS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GeneDx Holdings Corp. stock right from TradingView charts — choose your broker and connect to your account.
WGS reached its all-time high on Feb 12, 2021 with the price of 897.03 USD, and its all-time low was 1.16 USD and was reached on Nov 16, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪1.00 K‬ employees. See our rating of the largest employees — is GeneDx Holdings Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GeneDx Holdings Corp. EBITDA is ‪−127.69 M‬ USD, and current EBITDA margin is −63.10%. See more stats in GeneDx Holdings Corp. financial statements.